The changes of atrial complex on electrocardiogram in metabolic syndrome patients with cardiac arrhythmias
https://doi.org/10.15829/1728-8800-2016-5-39-42
Abstract
Aim. To study the parameters of P wave in metabolic syndrome (MS) patients and to evaluate their relation with cardiac rhythm disorders development.
Material and methods. Totally, 203 men studied with MS and 16
comparable by age men with arterial hypertension alone. All participants underwent 24-hour electrocardiogram monitoring (ECG), where the P wave length was measured, as Macruse index and length of negative P phase in lead V1. According to the presence of arrhythmia, patients were selected to groups: no arrhythmia, ventricular extrasistoly, supraventricular extrasystoly and atrial fibrillation.
Results. In supraventricular extrasistoly group and in paroxysmal atrial fibrillation group all parameters of atrial ECG were significantly increased and were higher than the same parameters in control group, as in patients with ventricular extrasistoly or no arrhythmia.
Conclusion. The increase of total P-wave duration and of negative
phase in lead V1, as well as Macruse index is associated with increased prevalence of supraventricular rhythm disorders in MS.
About the Authors
E. D. Dzhishambaev
M. Mirrakhimov National Canter of Cardiology and Therapy. Bishkek, Kyrgyzstan
Russian Federation
Russian Federation
S. I. Khakimova
M. Mirrakhimov National Canter of Cardiology and Therapy. Bishkek, Kyrgyzstan
Russian Federation
Russian Federation
N. O. Amanalieva
M. Mirrakhimov National Canter of Cardiology and Therapy. Bishkek, Kyrgyzstan
Russian Federation
Russian Federation
Yu. A. Kroshkin
M. Mirrakhimov National Canter of Cardiology and Therapy. Bishkek, Kyrgyzstan
Russian Federation
Russian Federation
References
1. Platonov PG. P-wave morphology: underlying mechanisms and clinical implications. Ann Noninvasive Electrocardiol 2012; 17(3): 161-9.
2. Lin Z, Hayano M, Hirata T, еt al. Abnormalities of electrocardiographic P wave morphology and the relationship to electrophysiological parameter of the atrium in patients with idiopathic paroxysmal atrial fibrillation. J Cardiol 1998; 32: 189-96.
3. Magnani JW, Lopez FL, Soliman EZ, et al. P wave indices, obesity, and the metabolic syndrome: the atherosclerosis risk in communities study. Obesity (Silver Spring) 2012; 20(3): 666-72.
4. Chamberlain AM, Agarwal SK, Ambrose M, et al. Metabolic syndrome and incidence of atrial fibrillation among blacks and whites in the Atherosclerosis Risk in Communities (ARIC) Study. Am Heart J 2010; 159(5): 850-6.
5. Abhayaratna WP, Seward JB, Appleton CP, et al. Left atrial size: physiologic determinants and clinical applications. JACC 2006; 47(12): 2357-63.
6. Henry WL, Morganroth J, Pearlman AS, et al. Relation between echocardiographically determined left atrial size and atrial fibrillation. Circulation 1976; 53: 273-8.
7. Aronow WS, Schwartz KS, Koenigsberg M. Prevalence of enlarged left atrial dimension by echocardiography and its correlation with atrial fibrallation and abnormal P force in lead V1 of the electrocardiogram in 588 elderly persons. Am J Cardiol 1987; 59: 1003-4.
8. Perez MV, Dewey FW, Marcus R, et al. Electrocardiographic predictors of atrial fibrillation. Am Heart J 2009; 158: 622-8.
9. Kosar F, Aksoy Y, Ari F, et al. P-wave duration and dispersion in obese subjects. Ann Noninvasive Electrocardiol 2008; 13(1): 3-7.
10. Yasar AS, Bilen E, Bilge M, et al. P-wave duration and dispersion in patients with metabolic syndrome. Pacing Clin Electrophysiol 2009; 32(9): 1168-72.
11. Liu T, Fu Z, Korantzopoulos P, et al. Effect of obesity on p-wave parameters in a Chinese population. Ann Noninvasive Electrocardiol 2010; 15(3): 259-63.
12. Umetani K, Kodama Y, Nakamura N, et al. High prevalence of paroxysmal atrial ibrillation ana/or flutter in metabolic syndrome. Circ J 2007; 71(2): 252-5.
13. Tanner RM, Baber U, Carson AP, et al. Association of the metabolic syndrome with atrial fibrillation among United States adults (from the REasons for Geographic and Racial Differences in Stroke [REGARDS] Study). Am J Cardiol 2011; 108(2): 227-32.
14. Watanabe H, Tanabe N, Watanabe T, et al. Metabolic syndrome and risk of development of atrial fibrillation: the Niigata preventive medicine study. Circulation 2008; 117(10): 1255- 60.
Review
For citations:
Dzhishambaev E.D., Khakimova S.I., Amanalieva N.O., Kroshkin Yu.A. The changes of atrial complex on electrocardiogram in metabolic syndrome patients with cardiac arrhythmias. Cardiovascular Therapy and Prevention. 2016;15(5):39-42. (In Russ.) https://doi.org/10.15829/1728-8800-2016-5-39-42
Views:
3382
Email this article 
